Research and development in Parkinson's disease

Today more than 40 novel drugs are in development for Parkinson's disease and related disorders. We continually assess and appraise this evolving drug development activity.

Our database of R&D activity is updated on an ongoing basis and empowers our provison of services to the biopharmaceutical and financial communities.